| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.759 | 0.003 | 0.924 | Non-steroidal antiinflammatory agent | 0.924 0.002 CID_154699991 | CID_154699991 | |
| 0.643 | 0.004 | 0.643 | Cyclooxygenase inhibitor | 0.483 0.005 CID_154699991 | ||
| 0.597 | 0.004 | 0.597 | Cyclooxygenase 2 inhibitor | 0.435 0.005 CID_154699991 | ||
| 0.622 | 0.048 | 0.791 | Antiinflammatory | 0.791 0.017 CID_154699991 | CID_154699991 | |
| 0.538 | 0.025 | 0.538 | Toll-Like receptor 7 agonist | 0.37 0.072 CID_154699991 | ||
| 0.533 | 0.026 | 0.533 | Toll-Like receptor agonist | 0.395 0.062 CID_154699991 | ||
| 0.511 | 0.005 | 0.511 | Cyclooxygenase 1 inhibitor | 0.379 0.008 CID_154699991 | ||
| 0.535 | 0.041 | 0.753 | Cyclophilin D inhibitor | 0.753 0.009 CID_154699991 | CID_154699991 | |
| 0.488 | 0.04 | 0.488 | Antiobesity | 0.455 0.048 CID_154699991 | ||
| 0.462 | 0.045 | 0.462 | Calcium channel L-type activator | |||
| 0.362 | 0.05 | 0.362 | Nootropic | |||
| 0.315 | 0.005 | 0.315 | Phosphodiesterase IV inhibitor | |||
| 0.301 | 0.005 | 0.301 | Phosphodiesterase 4B inhibitor | |||
| 0.266 | 0.008 | 0.266 | Aurora-C kinase inhibitor | 0.134 0.074 CID_154699991 | ||
| 0.311 | 0.066 | 0.311 | 5 Hydroxytryptamine release stimulant | |||
| 0.247 | 0.02 | 0.318 | Insulin secretagoues | 0.318 0.01 CID_154699991 | CID_154699991 | |
| 0.335 | 0.117 | 0.335 | Analgesic | |||
| 0.306 | 0.129 | 0.306 | MAP kinase kinase 6 inhibitor | |||
| 0.187 | 0.015 | 0.187 | Pregnane X receptor agonist | |||
| 0.177 | 0.015 | 0.177 | Hedgehog signaling inhibitor | 0.094 0.075 CID_154699991 | ||
| 0.164 | 0.004 | 0.164 | G protein-coupled receptor agonist | |||
| 0.159 | 0.003 | 0.159 | Liver X receptor beta antagonist | |||
| 0.164 | 0.009 | 0.164 | Phosphodiesterase 4A inhibitor | |||
| 0.19 | 0.038 | 0.19 | Phosphodiesterase inhibitor | |||
| 0.154 | 0.004 | 0.154 | Liver X receptor antagonist | 0.035 0.018 CID_154699991 | ||
| 0.188 | 0.048 | 0.212 | Interleukin 6 antagonist | 0.212 0.035 CID_154699991 | CID_154699991 | |
| 0.177 | 0.039 | 0.177 | Sodium channel (voltage-gated) blocker | |||
| 0.143 | 0.005 | 0.143 | Liver X receptor agonist | 0.047 0.026 CID_154699991 | ||
| 0.191 | 0.055 | 0.191 | Heat shock protein 90 alpha antagonist | |||
| 0.215 | 0.082 | 0.351 | Peptidyltransferase inhibitor | 0.351 0.012 CID_154699991 | CID_154699991 | |
| 0.211 | 0.08 | 0.211 | EphB2 antagonist | |||
| 0.131 | 0.004 | 0.131 | Liver X receptor beta agonist | |||
| 0.13 | 0.004 | 0.13 | Liver X receptor alpha agonist | |||
| 0.173 | 0.051 | 0.173 | Activin receptor-like kinase 2 inhibitor | |||
| 0.156 | 0.035 | 0.156 | MAP kinase 9 inhibitor | |||
| 0.161 | 0.046 | 0.161 | MAP3K9 inhibitor | |||
| 0.124 | 0.01 | 0.124 | Phosphodiesterase 4C inhibitor | |||
| 0.136 | 0.023 | 0.136 | Phosphodiesterase 4D inhibitor | |||
| 0.203 | 0.097 | 0.203 | Dyrk kinase inhibitor | |||
| 0.229 | 0.127 | 0.229 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.212 | 0.115 | 0.212 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.1 | 0.004 | 0.1 | Liver X receptor alpha antagonist | 0.031 0.017 CID_154699991 | ||
| 0.162 | 0.068 | 0.162 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.113 | 0.019 | 0.113 | Nav1.7 sodium channel blocker | |||
| 0.129 | 0.038 | 0.129 | MAP kinase 8 inhibitor | |||
| 0.093 | 0.004 | 0.093 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.119 | 0.032 | 0.119 | ABCA1 expression enhancer | |||
| 0.117 | 0.03 | 0.117 | Janus tyrosine kinase 2 inhibitor | |||
| 0.224 | 0.138 | 0.468 | Immunomodulator | 0.468 0.028 CID_154699991 | CID_154699991 | |
| 0.093 | 0.015 | 0.093 | Bromodomain-containing protein 4 inhibitor | |||
| 0.082 | 0.01 | 0.082 | DNA helicase inhibitor | 0.065 0.021 CID_154699991 | ||
| 0.144 | 0.075 | 0.144 | MAP kinase kinase 4 inhibitor | |||
| 0.174 | 0.107 | 0.174 | HERG channel blocker | |||
| 0.104 | 0.038 | 0.104 | ALK inhibitor | |||
| 0.12 | 0.055 | 0.12 | Nav1.5 sodium channel blocker | |||
| 0.174 | 0.11 | 0.174 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.134 | 0.071 | 0.134 | Sodium channel blocker | |||
| 0.19 | 0.128 | 0.19 | Cardiotonic | |||
| 0.074 | 0.014 | 0.074 | Smo receptor antagonist | |||
| 0.141 | 0.082 | 0.141 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.174 | 0.117 | 0.174 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.076 | 0.022 | 0.076 | Thromboxane antagonist | |||
| 0.091 | 0.038 | 0.091 | Focal adhesion kinase 1 inhibitor | |||
| 0.123 | 0.071 | 0.123 | MAP kinase kinase inhibitor | |||
| 0.182 | 0.131 | 0.516 | Hypoglycemic | 0.516 0.014 CID_154699991 | CID_154699991 | |
| 0.074 | 0.024 | 0.074 | GABA A receptor antagonist | |||
| 0.063 | 0.013 | 0.063 | Benzodiazepine inverse agonist | |||
| 0.112 | 0.063 | 0.112 | Activin receptor-like kinase 4 inhibitor | |||
| 0.093 | 0.045 | 0.093 | I kappa B kinase inhibitor | |||
| 0.087 | 0.04 | 0.087 | Janus tyrosine kinase 3 inhibitor | |||
| 0.126 | 0.08 | 0.126 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.1 | 0.056 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.099 | 0.056 | 0.099 | Potassium channel (Ca-activated) activator | |||
| 0.066 | 0.024 | 0.066 | Thromboxane A2 antagonist | |||
| 0.08 | 0.038 | 0.084 | Leukotriene synthesis inhibitor | 0.084 0.035 CID_154699991 | CID_154699991 | |
| 0.068 | 0.026 | 0.068 | GABA receptor antagonist | |||
| 0.079 | 0.037 | 0.079 | Tyk2 inhibitor | |||
| 0.204 | 0.164 | 0.352 | Caspase 3 stimulant | 0.352 0.058 CID_154699991 | CID_154699991 | |
| 0.051 | 0.011 | 0.051 | Cathepsin F inhibitor | 0.041 0.031 CID_154699991 | ||
| 0.067 | 0.027 | 0.067 | CC chemokine 2 receptor antagonist | |||
| 0.069 | 0.03 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.089 | 0.05 | 0.089 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.065 | 0.028 | 0.065 | Bcl-xL inhibitor | |||
| 0.131 | 0.094 | 0.49 | Hemostatic | 0.49 0.004 CID_154699991 | CID_154699991 | |
| 0.111 | 0.075 | 0.111 | Interleukin 8 antagonist | |||
| 0.111 | 0.076 | 0.111 | TRKA antagonist | |||
| 0.04 | 0.005 | 0.04 | Hexokinase stimulant | |||
| 0.073 | 0.041 | 0.073 | MAP kinase kinase 8 inhibitor | |||
| 0.098 | 0.066 | 0.098 | Bronchodilator | |||
| 0.033 | 0.003 | 0.033 | CC chemokine 9 receptor antagonist | |||
| 0.139 | 0.11 | 0.139 | LIM domain kinase 1 inhibitor | |||
| 0.088 | 0.06 | 0.088 | Bromodomain-containing protein 2 inhibitor | |||
| 0.079 | 0.052 | 0.079 | MAP kinase 10 inhibitor | |||
| 0.05 | 0.024 | 0.05 | Glutamate (mGluR group III) agonist | |||
| 0.041 | 0.015 | 0.041 | ATM kinase inhibitor | |||
| 0.059 | 0.033 | 0.059 | MAP kinase kinase 9 inhibitor | |||
| 0.075 | 0.052 | 0.075 | Porphobilinogen synthase inhibitor | |||
| 0.115 | 0.092 | 0.115 | Toll-Like receptor antagonist | |||
| 0.092 | 0.073 | 0.092 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.036 | 0.017 | 0.036 | ATR kinase inhibitor | |||
| 0.111 | 0.092 | 0.111 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.054 | 0.036 | 0.054 | Prostaglandin antagonist | |||
| 0.063 | 0.046 | 0.063 | Transcription factor RelA inhibitor | |||
| 0.067 | 0.052 | 0.067 | I kappa B kinase 1 inhibitor | |||
| 0.04 | 0.025 | 0.04 | Vascular adhesion protein 1 inhibitor | |||
| 0.022 | 0.007 | 0.022 | Sodium/hydrogen exchanger inhibitor | |||
| 0.018 | 0.005 | 0.018 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.06 | 0.047 | 0.06 | I kappa B kinase 2 inhibitor | |||
| 0.113 | 0.1 | 0.113 | Interleukin 1 antagonist | |||
| 0.097 | 0.086 | 0.097 | Aurora-B kinase inhibitor | |||
| 0.053 | 0.043 | 0.053 | Phosphodiesterase II inhibitor | |||
| 0.139 | 0.13 | 0.139 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.064 | 0.056 | 0.064 | Syk tyrosine kinase inhibitor | |||
| 0.053 | 0.047 | 0.053 | EphB4 antagonist | |||
| 0.111 | 0.105 | 0.111 | CDC-like kinase 1 inhibitor | |||
| 0.063 | 0.057 | 0.063 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Stearoyl-CoA desaturase inhibitor | |||
| 0.063 | 0.059 | 0.063 | Transforming growth factor antagonist | |||
| 0.043 | 0.039 | 0.043 | AMPA receptor antagonist | |||
| 0.037 | 0.034 | 0.037 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.119 | 0.126 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 CID_154699991 | CID_154699991 | |
| 0.14 | 0.172 | 0.399 | Tumour necrosis factor alpha release inhibitor | 0.399 0.027 CID_154699991 | CID_154699991 | |
| 0.1 | 0.141 | 0.223 | Anticoagulant | 0.223 0.046 CID_154699991 | CID_154699991 | |
| 0.015 | 0.058 | 0.042 | Sodium/glucose cotransporter 2 inhibitor | 0.042 0.008 CID_154699991 | CID_154699991 | |
| 0.171 | 0.218 | 0.525 | Antithrombotic | 0.525 0.026 CID_154699991 | CID_154699991 | |
| 0.225 | 0.286 | 0.272 | Caspase 9 stimulant | 0.272 0.226 CID_154699991 | CID_154699991 | |
| 0.036 | 0.106 | 0.066 | Nitric oxide donor | 0.066 0.038 CID_154699991 | CID_154699991 | |
| 0.033 | 0.105 | 0.056 | Cytokine production stimulant | 0.056 0.017 CID_154699991 | CID_154699991 | |
| 0.031 | 0.112 | 0.065 | Factor IXa inhibitor | 0.065 0.023 CID_154699991 | CID_154699991 | |
| 0.066 | 0.153 | 0.231 | AMP-activated protein kinase stimulant | 0.231 0.008 CID_154699991 | CID_154699991 | |
| 0.011 | 0.118 | 0.026 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 CID_154699991 | CID_154699991 | |
| 0.083 | 0.216 | 0.149 | DNA repair enzyme inhibitor | 0.149 0.033 CID_154699991 | CID_154699991 | |
| 0.026 | 0.176 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 CID_154699991 | CID_154699991 | |
| 0.049 | 0.207 | 0.108 | NADH dehydrogenase inhibitor | 0.108 0.037 CID_154699991 | CID_154699991 | |
| 0.063 | 0.228 | 0.185 | Cell adhesion inhibitor | 0.185 0.029 CID_154699991 | CID_154699991 | |
| 0.042 | 0.218 | 0.093 | Uric acid excretion stimulant | 0.093 0.061 CID_154699991 | CID_154699991 | |
| 0.079 | 0.259 | 0.221 | Hypolipemic | 0.221 0.081 CID_154699991 | CID_154699991 | |
| 0.077 | 0.302 | 0.127 | Interferon gamma antagonist | 0.127 0.117 CID_154699991 | CID_154699991 | |
| 0.066 | 0.309 | 0.153 | Antiamyloidogenic | 0.153 0.144 CID_154699991 | CID_154699991 | |
| 0.026 | 0.269 | 0.125 | Topoisomerase I inhibitor | 0.125 0.053 CID_154699991 | CID_154699991 | |
| 0.062 | 0.335 | 0.305 | Hepatoprotectant | 0.305 0.028 CID_154699991 | CID_154699991 | |
| 0.057 | 0.344 | 0.325 | Platelet adhesion inhibitor | 0.325 0.026 CID_154699991 | CID_154699991 | |
| 0.04 | 0.334 | 0.153 | Toll-Like receptor 4 antagonist | 0.153 0.019 CID_154699991 | CID_154699991 | |
| 0.01 | 0.346 | 0.252 | Selectin antagonist | 0.252 0.008 CID_154699991 | CID_154699991 | |
| 0.027 | 0.368 | 0.08 | Cell adhesion molecule inhibitor | 0.08 0.053 CID_154699991 | CID_154699991 | |
| 0.029 | 0.374 | 0.175 | Thrombolytic | 0.175 0.065 CID_154699991 | CID_154699991 | |
| 0.045 | 0.393 | 0.196 | Platelet antagonist | 0.196 0.104 CID_154699991 | CID_154699991 | |
| 0.049 | 0.408 | 0.193 | Vasodilator | 0.193 0.11 CID_154699991 | CID_154699991 | |
| 0.091 | 0.458 | 0.312 | Apoptosis antagonist | 0.312 0.078 CID_154699991 | CID_154699991 | |
| 0.022 | 0.393 | 0.106 | Topoisomerase II inhibitor | 0.106 0.08 CID_154699991 | CID_154699991 | |
| 0.025 | 0.419 | 0.055 | Adenine nucleotide translocase inhibitor | 0.055 0.04 CID_154699991 | CID_154699991 | |
| 0.049 | 0.451 | 0.186 | NOS3 expression enhancer | 0.186 0.047 CID_154699991 | CID_154699991 | |
| 0.013 | 0.42 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 CID_154699991 | CID_154699991 | |
| 0.095 | 0.505 | 0.413 | Interleukin 2 agonist | 0.413 0.024 CID_154699991 | CID_154699991 | |
| 0.036 | 0.454 | 0.351 | Free radical scavenger | 0.351 0.039 CID_154699991 | CID_154699991 | |
| 0.032 | 0.451 | 0.26 | Immunostimulant | 0.26 0.092 CID_154699991 | CID_154699991 | |
| 0.011 | 0.442 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 CID_154699991 | CID_154699991 | |
| 0.051 | 0.486 | 0.307 | Transcription factor NF kappa B inhibitor | 0.307 0.091 CID_154699991 | CID_154699991 | |
| 0.013 | 0.505 | 0.054 | Heparanase inhibitor | 0.054 0.035 CID_154699991 | CID_154699991 | |
| 0.07 | 0.562 | 0.402 | Apoptosis agonist | 0.402 0.112 CID_154699991 | CID_154699991 | |
| 0.023 | 0.525 | 0.427 | Angiogenesis stimulant | 0.427 0.018 CID_154699991 | CID_154699991 | |
| 0.032 | 0.539 | 0.235 | Nitric oxide antagonist | 0.235 0.056 CID_154699991 | CID_154699991 | |
| 0.032 | 0.541 | 0.085 | Transcription factor NF kappa B stimulant | 0.085 0.059 CID_154699991 | CID_154699991 | |
| 0.034 | 0.613 | 0.354 | Immunosuppressant | 0.354 0.084 CID_154699991 | CID_154699991 | |
| 0.023 | 0.602 | 0.345 | Antioxidant | 0.345 0.048 CID_154699991 | CID_154699991 | |
| 0.02 | 0.714 | 0.381 | Antibacterial | 0.381 0.086 CID_154699991 | CID_154699991 | |
| 0.008 | 0.759 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 CID_154699991 | CID_154699991 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |